Fingerprint
Dive into the research topics of 'Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1‐JAK2, BCR‐JAK2 and ETV6‐ABL1 fusion genes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1‐JAK2, BCR‐JAK2 and ETV6‐ABL1 fusion genes
Juliana Schwaab, Nicole Naumann, Johannes Luebke, Mohamad Jawhar, Tim C.p. Somervaille, Mark Williams, Rebecca Frewin, Philipp J. Jost, Felix S. Lichtenegger, Paul La Rosée, Nicola Storch, Torsten Haferlach, Hans‐peter Horny, Alice Fabarius, Claudia Haferlach, Andreas Burchert, Wolf‐karsten Hofmann, Nicholas C.p. Cross, Andreas Hochhaus, Andreas Reiter
- Medical Facility Mannheim - University of Heidelberg
- Gloucester Royal Hospital
- Klinikum Rechts der Isar - Technische Universität München
- Klinikum der Universitat Munchen ( University of Munich )
- Schwarzwald‐Baar‐Klinikum
- St. Vincenz Medical Centre Limburg
- MLL Munich Leukemia Laboratory
- Ludwig-Maximilians-Universitat Munchen
- Universitatsklinikum Giessen und Marburg, Standort Marburg
- Salisbury NHS Foundation Trust
- Universitätsklinikum Jena
- University of Southampton
- The Christie Hospital NHS Foundation Trust
- Ruprecht-Karls Universitat Heidelberg - University of Heidelberg
- Phillips Universitat Marburg
Research output: Contribution to journal › Article › peer-review